What is the Return on Assets (ROA) of Progenity this year?
The Return on Assets (ROA) of Progenity is 0 undefined this year.
Progenity ROA 2025
Progenity ROA
0
Ticker
PROG
ISIN
US74319F1075
WKN
A2P7FX
In 2025, Progenity's return on assets (ROA) was 0, a 0% increase from the 0 ROA in the previous year.
Progenity Aktienanalyse
What does Progenity do?
Progenity Inc. is an American company specializing in the development and marketing of diagnostic tests and genetic screening solutions. It was founded in 2012 and is headquartered in San Diego, California. Progenity is a leading provider of prenatal screening and diagnostic solutions. The company offers a wide range of tests that help expectant parents identify potential health risks for their unborn child. Progenity's prenatal screening palette includes tests for determining chromosomal abnormalities, genetic disorders, and other health risks. A major advantage of these tests is that they are non-invasive, meaning that no dangerous invasive procedures need to be performed. Another important division of Progenity focuses on gastrointestinal health, where the company offers various diagnostic tests to identify and treat gastrointestinal diseases early. This includes tests for detecting colon cancer as well as genetic tests that indicate an increased risk for familial colon cancer syndromes. Progenity also has a division that focuses on cardiovascular diseases. Here, they offer genetic tests, among other things, to determine the risk of heart disease. In addition, the company offers a wide range of diagnostic solutions for general health, such as tests for identifying infectious diseases like HIV or HPV. Progenity also offers its customers various screening and diagnostic tests tailored to specific target groups. This includes tests for women seeking fertility treatment, as well as tests aiming to identify specific hereditary diseases related to cancer or other conditions. To provide customers with the best possible solutions, Progenity utilizes state-of-the-art technologies and innovative methods. The company is a leader in the application of liquid biopsy tests, an innovative method for identifying cancer cells in the blood. For a long time, Progenity has worked closely with leading US health authorities and is accredited by CLIA, the Clinical Laboratory Improvement Amendments. This means that the company operates in accordance with established standards and best practices and can provide its customers with accurate and reliable diagnostic solutions. In recent years, Progenity has experienced an impressive growth rate and has become a recognized provider of diagnostic solutions with a wide range of tests covering various areas of health. The company is committed to providing customers with the best possible solutions to promote their health and well-being. Progenity ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Progenity's Return on Assets (ROA)
Progenity's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Progenity's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Progenity's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Progenity’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Progenity stock
What was the ROA of Progenity compared to the previous year?
The ROA of Progenity has increased by 0% compared to the previous year.
What consequences do high ROA have for investors of Progenity?
A high ROA is advantageous for investors of Progenity, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Progenity?
A low ROA can be unfavorable for investors of Progenity as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Progenity affect the company?
An increase in ROA of Progenity can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Progenity impact the company?
A reduction in the ROA of Progenity can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Progenity?
Some factors that can influence the ROA of Progenity include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Progenity important for investors?
The ROA of Progenity is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Progenity take to improve ROA?
To improve ROA, Progenity can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Progenity pay?
Over the past 12 months, Progenity paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Progenity is expected to pay a dividend of 0 USD.
What is the dividend yield of Progenity?
The current dividend yield of Progenity is .
When does Progenity pay dividends?
Progenity pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Progenity?
Progenity paid dividends every year for the past 0 years.
What is the dividend of Progenity?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Progenity located?
Progenity is assigned to the 'Health' sector.
Wann musste ich die Aktien von Progenity kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Progenity from 7/1/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/1/2025.
When did Progenity pay the last dividend?
The last dividend was paid out on 7/1/2025.
What was the dividend of Progenity in the year 2024?
In the year 2024, Progenity distributed 0 USD as dividends.
In which currency does Progenity pay out the dividend?
The dividends of Progenity are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Progenity
Our stock analysis for Progenity Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Progenity Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
